2007
DOI: 10.1016/j.mcna.2007.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Future Approaches of Nanomedicine in Clinical Science

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(17 citation statements)
references
References 163 publications
0
17
0
Order By: Relevance
“…Promoted by the National Institutes of Health of the United States, nanomedical research is providing easy access to innovative nanodevices and nanosystems based on the rational design and precise integration of functional nanomaterials for the further development of clinical nanomedicine [42] . Nanotechnology will enable design and delivery of more effective drugs with targeted delivery increasing efficacy and reducing toxicity.…”
Section: Future Potential Of Nanomedicinementioning
confidence: 99%
“…Promoted by the National Institutes of Health of the United States, nanomedical research is providing easy access to innovative nanodevices and nanosystems based on the rational design and precise integration of functional nanomaterials for the further development of clinical nanomedicine [42] . Nanotechnology will enable design and delivery of more effective drugs with targeted delivery increasing efficacy and reducing toxicity.…”
Section: Future Potential Of Nanomedicinementioning
confidence: 99%
“…Conjugation of pharmaceuticals to dendrimers, or artificial proteins, achieves similar results, and with the addition of site-specific surface antibodies, also allows for targeted drug delivery, resulting in decreased systemic adverse effects [16]. This strategy has demonstrated efficacy in the treatment of arthritis in rats utilizing conjugated indomethacin, with sites of inflammation targeted by a factor of 2.29 compared with unconjugated indomethacin [18]. Overall, application of nanotechnology to pharmacotherapy (e.g., analgesic, antibiotic, thrombolytic, etc.)…”
Section: Pharmacotherapymentioning
confidence: 99%
“…Namgung et al (2011) observed that SNT functionalized with a complexing agent (branched polyethylenimine) enhanced MRI signals in addition to appreciable cellular uptake . In vivo imaging can be performed by the use of imaging techniques that already exist, including single photon emission CT (SPECT), positron emission tomography (PET), MRI, fl uorescence microscopy, CT and ultrasound (Brewer et al ., 2007). Also, silica nanoparticles with modifi ed fl uorescent dyes have been shown to be effective in immunostaining and in vivo imaging (Liu et al ., 2010b).…”
Section: Imagingmentioning
confidence: 99%